SCHEMBL4154803

SCHEMBL4154803

Fc1c(F)c(F)c(-c2ccc3ccccc3c2)c(F)c1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.50
CYP2A6 P11509 2/20 0.50
ESR1 P03372 2/20 0.48
ESR2 Q92731 2/20 0.48
GSTP1 P09211 1/20 0.48
ALOX5 P09917 1/20 0.47
HSD17B1 P14061 1/20 0.45
HSD17B2 P37059 1/20 0.45
CYP11B1 P15538 3/20 0.44
CYP11B2 P19099 3/20 0.44
HDAC4 P56524 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
IKBKB O14920 1/20 0.43
CYP17A1 P05093 1/20 0.42
CYP19A1 P11511 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28233058 0.88 IKBKB (0.46) CYP1A2CYP2A6ESR1ESR2GSTP1
SCHEMBL15077937 0.87 CYP1A2 (0.39) CYP1A2CYP2A6ESR1ESR2GSTP1
SCHEMBL28112435 0.87 CYP1A2 (0.46) CYP1A2CYP2A6ESR1ESR2GSTP1
SCHEMBL16749875 0.86 CYP1A2 (0.42) CYP1A2CYP2A6ESR1ESR2GSTP1
SCHEMBL23312096 0.86 ESR1 (0.45) CYP1A2CYP2A6ESR1ESR2GSTP1
SCHEMBL28112982 0.84 ESR1 (0.46) CYP1A2CYP2A6ESR1ESR2GSTP1
SCHEMBL28112436 0.83 CYP1A2 (0.46) CYP1A2CYP2A6ESR1ESR2GSTP1
SCHEMBL17711200 0.83 PDE9A (0.50) CYP1A2CYP2A6ESR1ESR2GSTP1
SCHEMBL26750845 0.82 GSTP1 (0.42) CYP1A2CYP2A6ESR1ESR2GSTP1
SCHEMBL15854434 0.81 CYP1A2 (0.44) CYP1A2CYP2A6ESR1ESR2GSTP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8952207-B2 Copper-catalyzed C—H bond arylation THE UNIVERSITY OF HOUSTON SYSTEM (US) 2015-02-10 US disclosed
US-20090076266-A1 COPPER-CATALYZED C-H BOND ARYLATION THE UNIVERSITY OF HOUSTON SYSTEM (US) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076266-A1 COPPER-CATALYZED C-H BOND ARYLATION AOC2, AOC3, DBH CYP1A2 61/4885CYP2A6 45/4885ESR1 792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.